4
Changes in Ownership
Verrica Pharmaceuticals Inc. Filed Acc 0001209191-23-043301
Chief Commercial Officer sold 38,262 shares at $4.83 ($184,805)
- Chief Commercial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonaccorso Joe Chief Commercial Officer | 2023-07-21 | Grant or award | +100,000 | 101,000 | D: show line 1 in the form | ||
| Bonaccorso Joe Chief Commercial Officer | 2023-07-24 | Sale | −38,262 | $4.83 | $184,805 | 62,738 | D: show line 2 in the form |
| Open-market sales · 38,262 sh · avg $4.83 · $184,805 | |||||||
Loading xslF345X05/doc4.xml…